Answers are grounded in this paper and cite their sources.
Background/Objectives: Atopic dermatitis (AD) is a prevalent, recurrent, cutaneous disease marked by impaired epidermal barrier function and aberrant immune responses. Despite advancing therapies for AD, their efficacy is limited by adverse effects and relapse. This study evaluated the potential efficacy and immunomodulatory properties of a water extract of Loranthus parasiticus (WELP). Methods: Chemical profiling of WELP was conducted using ultra-high-performance liquid chromatography–tandem mass spectrometry (UHPLC-MS/MS). Its immunomodulatory properties were preliminarily evaluated in concanavalin A (Con A)-stimulated primary murine splenocytes and evaluated in a Dermatophagoides farinae extract (DfE)-induced AD mouse model. Furthermore, in silico molecular docking simulations were performed against key signaling targets: IκB kinase β (IKKβ), Janus kinases 1 and 2 (JAK1 and JAK2), signal transducer and activator of transcription (STAT) proteins 3 and 6. Results: UHPLC-MS/MS identified seven main phytochemicals: gallic acid, glucogallin, catechin, epicatechin, procyanidin B2, protocatechuic acid, and quercitrin. In Con A-stimulated splenocytes, WELP modulated cytokine production, displaying contrasting patterns particularly between interleukin (IL)-22 and Tumor Necrosis Factor-alpha (TNF-α). In DfE-induced AD mice, oral administration of WELP improved clinical dermatitis scores and ear thickness, while transepidermal water loss (TEWL) was significantly improved at the high dose. Histopathological analysis confirmed that WELP attenuated epidermal hyperplasia and reduced cutaneous infiltration of mast cells and eosinophils. Furthermore, WELP decreased serum levels of immunoglobulin E (IgE), histamine, and diverse inflammatory chemokines. In lesional skin, WELP suppressed the mRNA expression of epithelial alarmins—thymic stromal lymphopoietin (TSLP) and IL-25—and diminished protein levels of Th2-, Th1-, Th17-, and Th22-associated cytokines. In silico docking predicted binding affinities between WELP constituents and IKKβ, JAK1, JAK2, STAT3, and STAT6. Conclusions: WELP effectively alleviated DfE-induced AD-like skin inflammation through broad modulation of inflammatory mediators involved in AD pathogenesis. These findings suggest that WELP is a promising preclinical candidate for AD that warrants further evaluation.
No takes yet. Share an insight, caveat, or question.
Gu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: